|4Mar 21, 3:09 PM ET

ZIMMER BIOMET HOLDINGS, INC. 4

4 · ZIMMER BIOMET HOLDINGS, INC. · Filed Mar 21, 2017

Insider Transaction Report

Form 4
Period: 2017-03-17
DVORAK DAVID C
DirectorPresident and CEO
Transactions
  • Tax Payment

    Common Stock

    2017-03-17$120.47/sh11,151$1,343,361282,926 total
  • Exercise/Conversion

    Restricted Stock Units

    2017-03-1723,9290 total
    Common Stock (23,929 underlying)
  • Exercise/Conversion

    Common Stock

    2017-03-17+23,929294,077 total
  • Sale

    Common Stock

    2017-03-20$121.63/sh1,040$126,495281,886 total
Footnotes (5)
  • [F1]Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units.
  • [F2]Securities sold to cover additional taxes on the vesting of restricted stock units pursuant to a written plan intended to comply with Rule 10b5-1(c)(1) adopted by Mr. Dvorak on September 14, 2016.
  • [F3]Represents the sale of 1,040 shares in multiple transactions, ranging in price from $121.55 to $121.69 per share, resulting in a weighted average sale price of $121.627. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
  • [F4]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.
  • [F5]The earned RSUs vested on March 17, 2017.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT